Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 461-466

  Paakkanen, Riitta ^a,b   Lokki, Marja Liisa ^b   Seppänen, Mikko ^a   Tierala, Ilkka ^a   Nieminen, Markku S ^a   Sinisalo, Juha ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

01; Acute coronary syndrome; Genetic predisposition; HLA DRB1; Inflammation; ST elevation myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; HLA DRB1 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 84858709079     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.024     Document Type: Article

References (28)

1. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011, 12:204-212.
2. Andreotti F., Marchese N. Women and coronary disease. Heart 2008, 94:108-116.
3. Wensley F., Gao P., et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011, 342:d548. C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC).
4. Fishbein M.C. The vulnerable and unstable atherosclerotic plaque. Cardiovasc Pathol 2010, 19:6-11.
5. Ino Y., Kubo T., Tanaka A., et al. Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. JACC Cardiovasc Interv 2011, 4:76-82.
6. Klein J., Sato A. The HLA system. First of two parts. N Engl J Med 2000, 343:702-709.
7. Palikhe A., Sinisalo J., Seppanen M., et al. Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease. Tissue Antigens 2007, 69:47-55.
8. Sun W., Cui Y., Zhen L., et al. Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4(+)CD28(null) T cells in a Chinese population with coronary heart disease. Mol Biol Rep 2011, 38:1675-1679.
9. Bjorkbacka H., Lavant E.H., Fredrikson G.N., et al. Weak associations between human leucocyte antigen genotype and acute myocardial infarction. J Int Med 2010, 268:50-58.
10. Tierala I., Nikus K.C., Sclarovsky S., et al. Predicting the culprit artery in acute ST-elevation myocardial infarction and introducing a new algorithm to predict infarct-related artery in inferior ST-elevation myocardial infarction: correlation with coronary anatomy in the HAAMU trial. J Electrocardiol 2009, 42:120-127.
11. Vaara S., Nieminen M.S., Lokki M.L., et al. Cohort profile: the Corogene Study. Int J Epidemiol 2011.
12. Seppanen M., Suvilehto J., Lokki M.L., et al. Immunoglobulins and complement factor C4 in adult rhinosinusitis. Clin Exp Immunol 2006, 145:219-227.
13. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
14. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
15. Aromaa A., Koskinen S. Health and functional capacity in Finland. Baseline Result of the Health 2000 Examination Survey 2002.
16. Jonasson L., Eriksson T., Dahle'n G.H., et al. Lipoprotein(a) and HLA-DRB1 and -DQB1 genes in coronary artery disease. Atherosclerosis 1997, 133:111-114.
17. Shen J., Ordovas J.M. Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents. Clin Chem 2009, 55:256-264.
18. Porto I., Leone A.M., Crea F., et al. Inflammation, genetics, and ischemic heart disease: focus on the major histocompatibility complex (MHC) genes. Cytokine 2005, 29:187-196.
19. Hermann R., Turpeinen H., Laine A.P., et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003, 62:162-169.
20. Ploski R., Ascher H., Sollid L.M. HLA genotypes and the increased incidence of coeliac disease in Sweden. Scand J Gastroenterol 1996, 31:1092-1097.
21. Williams P., Pendyala L., Superko R. Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease. BMC Med Genet 2011, 12:42.
22. Handunnetthi L., Ramagopalan S.V., Ebers G.C., et al. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immunol 2010, 11:99-112.
23. Wakim L.M., Bevan M.J. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 2011, 471:629-632.
24. Zhou G., Ding Z.C., Fu J., et al. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response. J Immunol 2011, 186:2148-2155.
25. Hassan G.S., Mourad W. An unexpected role for MHC class II. Nat Immunol 2011, 12:375-376.
26. Swanberg M., Lidman O., Padyukov L., et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005, 37:486-494.
27. Pajewski N.M., Parker S.D., Poland G.A., et al. The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed. Genes Immunol 2011, 12:457-465.
28. Baumgart M., Moos V., Schuhbauer D., et al. Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects. Proc Natl Acad Sci USA 1998, 95:6936-6940.